NCT06997185 Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs
| NCT ID | NCT06997185 |
| Status | Recruiting |
| Phase | — |
| Sponsor | London School of Economics and Political Science |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2025-05-09 |
| Primary Completion | 2025-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,000 participants in total. It began in 2025-05-09 with a primary completion date of 2025-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This nationally representative randomized survey of US adults will evaluate the effect of using brief statements to communicate different sources of uncertainty about the benefits and harms of new cancer drugs on participants' decisions and understanding.
Eligibility Criteria
Inclusion Criteria: * Adults 18 years of age and older * Adults fluent in English * Adults residing in the United States Exclusion Criteria: * Participants who do not meet each of the 3 inclusion criteria
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06997185 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06997185 currently recruiting?
Yes, NCT06997185 is actively recruiting participants. Contact the research team at a.j.cherla@lse.ac.uk for enrollment information.
Where is the NCT06997185 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT06997185 clinical trial?
NCT06997185 is sponsored by London School of Economics and Political Science. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.